Abstract
The role of modelling in economic evaluation is explored by discussing, with examples, the uses of models. The expanded use of pragmatic clinical trials as an alternative to models is discussed. Some suggestions for good modelling practice are made. (C) 1997 by John Wiley & Sons, Ltd.
Original language | English |
---|---|
Pages (from-to) | 217-27 |
Number of pages | 11 |
Journal | Health Economics |
Volume | 6 |
Issue number | 3 |
Publication status | Published - 1997 |
Keywords
- cost-effectiveness analysis
- resource allocation
- decision trees
- economic evaluation
- clinical trials
- SEROTONIN REUPTAKE INHIBITORS
- ACUTE MYOCARDIAL-INFARCTION
- CORONARY HEART-DISEASE
- COST-EFFECTIVENESS
- PROPHYLACTIC USE
- GASTRIC-ULCER
- DOUBLE-BLIND
- THERAPY
- METAANALYSIS
- PREVENTION